These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 31187224)

  • 21. Efficacy of mangiferin against Cryptosporidium parvum in a neonatal mouse model.
    Perrucci S; Fichi G; Buggiani C; Rossi G; Flamini G
    Parasitol Res; 2006 Jul; 99(2):184-8. PubMed ID: 16547730
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular identification and antiprotozoal activity of silver nanoparticles on viability of Cryptosporidium parvum isolated from pigeons, pigeon fanciers and water.
    Abou Elez RMM; Attia ASA; Tolba HMN; Anter RGA; Elsohaby I
    Sci Rep; 2023 Feb; 13(1):3109. PubMed ID: 36813872
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Investigations of the relationship between use of in vitro cell culture-quantitative PCR and a mouse-based bioassay for evaluating critical factors affecting the disinfection performance of pulsed UV light for treating Cryptosporidium parvum oocysts in saline.
    Garvey M; Farrell H; Cormican M; Rowan N
    J Microbiol Methods; 2010 Mar; 80(3):267-73. PubMed ID: 20096310
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of pyrvinium pamoate against Cryptosporidium parvum infection in vitro and in a neonatal mouse model.
    Downey AS; Chong CR; Graczyk TK; Sullivan DJ
    Antimicrob Agents Chemother; 2008 Sep; 52(9):3106-12. PubMed ID: 18591280
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Curcumin: A promising treatment for Cryptosporidium parvum infection in immunosuppressed BALB/c mice.
    Asadpour M; Namazi F; Razavi SM; Nazifi S
    Exp Parasitol; 2018 Dec; 195():59-65. PubMed ID: 30385266
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A new approach for targeting to Cryptosporidium parvum using mucoadhesive nanosuspensions: research and applications.
    Kayser O
    Int J Pharm; 2001 Feb; 214(1-2):83-5. PubMed ID: 11282242
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of molecular markers for determining the viability and infectivity of Cryptosporidium oocysts and validation of molecular methods against animal infectivity assay.
    Alum A; Rubino JR; Khalid Ijaz M
    Int J Infect Dis; 2011 Mar; 15(3):e197-200. PubMed ID: 21185212
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibitory effect of selenium on Cryptosporidium parvum infection in vitro and in vivo.
    Huang K; Yang S
    Biol Trace Elem Res; 2002; 90(1-3):261-72. PubMed ID: 12666840
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of oregano essential oil and carvacrol on Cryptosporidium parvum infectivity in HCT-8 cells.
    Gaur S; Kuhlenschmidt TB; Kuhlenschmidt MS; Andrade JE
    Parasitol Int; 2018 Apr; 67(2):170-175. PubMed ID: 29155281
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bobel-24 activity against Cryptosporidium parvum in cell culture and in a SCID mouse model.
    Rueda C; Fenoy S; Simón F; Del Aguila C
    Antimicrob Agents Chemother; 2008 Mar; 52(3):1150-2. PubMed ID: 18160525
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of UV-induced thymine dimers in individual Cryptosporidium parvum and Cryptosporidium hominis oocysts by immunofluorescence microscopy.
    Al-Adhami BH; Nichols RA; Kusel JR; O'Grady J; Smith HV
    Appl Environ Microbiol; 2007 Feb; 73(3):947-55. PubMed ID: 17012589
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Survival of Cryptosporidium parvum oocysts in the presence of hydrated lime.
    Zintl A; Keogh B; Ezzaty-Mirhashemi M; De Waal T; Scholz D; Mulcahy G
    Vet Rec; 2010 Mar; 166(10):297-300. PubMed ID: 20208077
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel CDPK1 inhibitor--a potential treatment for cryptosporidiosis in calves?
    Lendner M; Böttcher D; Delling C; Ojo KK; Van Voorhis WC; Daugschies A
    Parasitol Res; 2015 Jan; 114(1):335-6. PubMed ID: 25398685
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of resistance to γ-irradiation between Cryptosporidium parvum and Cryptosporidium muris using in vivo infection.
    Yoon S; Yu JR
    Korean J Parasitol; 2011 Dec; 49(4):423-6. PubMed ID: 22355212
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of anti-oxidant preparation (oxi-guard) on Cryptosporidium parvum infection in albino mice.
    Yassien NA; Khalifa EA; el-Nouby KA
    J Egypt Soc Parasitol; 2001 Apr; 31(1):95-106. PubMed ID: 12557933
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of two peroxygen-based disinfectants for inactivation of Cryptosporidium parvum oocysts.
    Quilez J; Sanchez-Acedo C; Avendaño C; del Cacho E; Lopez-Bernad F
    Appl Environ Microbiol; 2005 May; 71(5):2479-83. PubMed ID: 15870337
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A high-throughput phenotypic screen identifies clofazimine as a potential treatment for cryptosporidiosis.
    Love MS; Beasley FC; Jumani RS; Wright TM; Chatterjee AK; Huston CD; Schultz PG; McNamara CW
    PLoS Negl Trop Dis; 2017 Feb; 11(2):e0005373. PubMed ID: 28158186
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effect of the mixed-oxidant solution on infectivity of Cryptosporidium parvum oocysts in a neonatal mouse model].
    Sasahara T; Aoki M; Sekiguchi T; Takahashi A; Satoh Y; Kitasato H; Inoue M
    Kansenshogaku Zasshi; 2003 Feb; 77(2):75-82. PubMed ID: 12661082
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interactions between free-living amoebae and Cryptosporidium parvum: an experimental study.
    Lefebvre M; Razakandrainibe R; Schapman D; François A; Genty D; Galas L; Villena I; Favennec L; Costa D
    Parasite; 2023; 30():31. PubMed ID: 37606589
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A cysteine protease inhibitor rescues mice from a lethal Cryptosporidium parvum infection.
    Ndao M; Nath-Chowdhury M; Sajid M; Marcus V; Mashiyama ST; Sakanari J; Chow E; Mackey Z; Land KM; Jacobson MP; Kalyanaraman C; McKerrow JH; Arrowood MJ; Caffrey CR
    Antimicrob Agents Chemother; 2013 Dec; 57(12):6063-73. PubMed ID: 24060869
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.